Diabetes: A risk factor for glaucoma?

British Journal of Ophthalmology

Volumn 95, Issue 12, 2011, Pages 1621-1622

  Primus, Sally ^a   Harris, Alon ^a   Siesky, Brent A ^a   Guidoboni, Giovanna ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; NITRIC OXIDE;

BRAIN BLOOD FLOW; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; EDITORIAL; GLAUCOMA; GLOMERULUS FILTRATION RATE; HUMAN; INTRAOCULAR PRESSURE; MOLECULAR PATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN FUNCTION; RETINA BLOOD FLOW; RISK ASSESSMENT; RISK FACTOR; VISUAL ACUITY; VISUAL FIELD DEFECT;

DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; GLAUCOMA; HUMANS; RISK FACTORS; UNITED STATES;

EID: 81555228711     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2011-300788     Document Type: Editorial

References (25)

1. NIH National Eye Institute. 'Vision Loss from Eye Diseases Will Increase as Americans Age' April 12, 2004. 2011. http://www.nei.nih.gov/news/ pressreleases/041204.asp (accessed 18 Jul 2011).
2. Klein BE, Klein R, Jensen SC. Open-angle glaucoma and older-onset diabetes. The Beaver Dam Eye Study. Ophthalmology 1994;101:1173-7. (Pubitemid 24236073)
3. Dielemans I, de Jong PT, Stolk R, et al. Primary open-angle glaucoma, intraocular pressure, and diabetes mellitus in the general elderly population. The Rotterdam Study. Ophthalmology 1996;103:1271-5. (Pubitemid 26282511)
4. Nouri-Mahdavi K, Hoffman D, Coleman AL, et al. Predictive factors for glaucomatous visual field progression in Advanced Glaucoma Intervention Study. Ophthalmology 2004;111:1627-35. (Pubitemid 39179673)
5. Tielsch JM, Katz J, Sommer A, et al. Hypertension, perfusion pressure, and primary open-angle glaucoma. A population based assessment. Arch Ophthalmol 1995;113:216-21.
6. Quigley HA, West SK, Rodriguez J, et al. The prevalence of glaucoma in a population-based study of Hispanic subjects: Proyecto VER. Arch Ophthalmol 2001;119:1819-26. (Pubitemid 33139614)
7. Sommer A, Tielsch JM, Katz J, et al. Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. The Baltimore Eye Survey. Arch Ophthalmol 1991;109:1090-5.
8. Bonomi L, Marchini G, Marraffa M, et al. Vascular risk factors for primary open angle glaucoma: the EgnaeNeumarkt Study. Ophthalmology 2000;107:1287-93.
9. Orzalesi N, Rossetti L, Omboni S, et al. OPTIME Study Group (Osservatorio sulla Patologia glaucomatosa, Indagine Medico Epidemiologica); CONPROSO (Collegio Nazionale dei Professori Ordinari di Scienze Oftalmologiche). Vascular risk factors in glaucoma: the results of a national survey. Graefes Arch Clin Exp Ophthalmol 2007;245:795-802.
10. Akarsu C, Bilgili MY. Color Doppler imaging in ocular hypertension and open-angle glaucoma. Graefes Arch Clin Exp Ophthalmol 2004;242:125-9. (Pubitemid 38324965)
11. Logan JF, Rankin SJ, Jackson AJ. Retinal blood flow measurements and neuroretinal rim damage in glaucoma. Br J Ophthalmol 2004;88:1049-54. (Pubitemid 39013148)
12. Ludovico J, Bernardes R, Pires I, et al. Alterations of retinal capillary blood flow in preclinical retinopathy in subjects with type 2 diabetes. Graefes Arch Clin Exp Ophthalmol 2003;241:181-6. (Pubitemid 36747810)
13. Dimitroya G, Kato S, Yamashita H, et al. Relation between retrobulbar circulation and progression of diabetic retinopathy. Br J Ophthalmol 2003;87:622-5. (Pubitemid 36535338)
14. Kannel WB, McGee DL. Diabetes and cardiovascular risk factors: the Framingham study. Circulation 1979;59:8-13. (Pubitemid 9082394)
15. Stroman GA, Stewart WC, Golnik KC, et al. Magnetic resonance imaging in patients with low-tension glaucoma. Arch Ophthalmol 1995;113:168-72.
16. Zhang L, Krzentowski G, Albert A, et al. Risk of developing retinopathy in diabetes control and complications trial type 1 diabetic patients with good or poor metabolic control. Diabetes Care 2001;24:1275-9. (Pubitemid 33716411)
17. Balluz LS, Okoro CA, Mokdad A. Association between selected unhealthy lifestyle factors, body mass index, and chronic health conditions among individuals 50 years or age or older, by race/ethnicity. Ethn Dis 2008;18:450-7.
18. McGill JB. Improving microvascular outcomes in patients with diabetes through management of hypertension. Postgrad Med 2009;121:89-101.
19. Berisha F, Feke GT, Hirose T, et al. Retinal blood flow and nerve fiber layer measurements in early-stage open-angle glaucoma. Am J Ophthalmol 2008;146:466-72.
20. Krentz AJ, Clough G, Byrne CD. Interactions between microvascular and macrovascular disease in diabetes: pathophysiology and therapeutic implications. Diabetes Obes Metab 2007;9: 781-91. (Pubitemid 47555201)
21. van Hecke MV, Dekker JM, Nijpels G, et al. Are retinal microvascular abnormalities associated with large artery endothelial dysfunction and intima-media thickness? The Hoorn Study. Clin Sci (Lond) 2006;110:597-604. (Pubitemid 43736122)
22. Creager MA, Lüscher TF, Cosentino F, et al. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I. Circulation 2003;108:1527-32. (Pubitemid 37176462)
23. Liu B, Neufeld AH. Activation of epidermal growth factor receptor signals induction of nitric oxide synthase-2 in human optic nerve head astrocytes in glaucomatous optic neuropathy. Neurobiol Dis 2003;13:109-23. (Pubitemid 36793976)
24. Liao Q, Wang DH, Sun HJ. Association of genetic polymorphisms of eNOS with glaucoma. Mol Vis 2011;17:153-8.
25. Iwabe S, Lamas M, Vasquez Pelaez CG, et al. Aqueous humor endothelin-1 (ET-1), vascular endothelial growth factor (VEGF) and cyclooxygenase-2 (COX-2) levels in Mexican glaucomatous patients. Curr Eye Res 2010;35:287-94.